We recently published a list of 11 AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at ...

Stifel analysts adjusted their outlook on CRISPR Therapeutics (NASDAQ:CRSP), currently trading at $43.09 with a market capitalization of $3.7 billion, reducing the price target to $49 from the ...